LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,424,003
تعداد دریافت فایل اصل مقاله11,296,630
Sami, Ramin, Hajian, Mohammad-Reza, Amra, Babak, Soltaninejad, Forogh, Mansourian, Marjan, Mirfendereski, Sam, Sadegh, Raheleh, Khademi, Nilufar, Jalali, Soheila, Shokri-Mashhadi, Nafiseh. (1400). Risk Factors for the Mortality in Hospitalized Patients with COVID-19: A Brief Report. سامانه مدیریت نشریات علمی, 46(6), 487-492. doi: 10.30476/ijms.2021.47835
Ramin Sami; Mohammad-Reza Hajian; Babak Amra; Forogh Soltaninejad; Marjan Mansourian; Sam Mirfendereski; Raheleh Sadegh; Nilufar Khademi; Soheila Jalali; Nafiseh Shokri-Mashhadi. "Risk Factors for the Mortality in Hospitalized Patients with COVID-19: A Brief Report". سامانه مدیریت نشریات علمی, 46, 6, 1400, 487-492. doi: 10.30476/ijms.2021.47835
Sami, Ramin, Hajian, Mohammad-Reza, Amra, Babak, Soltaninejad, Forogh, Mansourian, Marjan, Mirfendereski, Sam, Sadegh, Raheleh, Khademi, Nilufar, Jalali, Soheila, Shokri-Mashhadi, Nafiseh. (1400). 'Risk Factors for the Mortality in Hospitalized Patients with COVID-19: A Brief Report', سامانه مدیریت نشریات علمی, 46(6), pp. 487-492. doi: 10.30476/ijms.2021.47835
Sami, Ramin, Hajian, Mohammad-Reza, Amra, Babak, Soltaninejad, Forogh, Mansourian, Marjan, Mirfendereski, Sam, Sadegh, Raheleh, Khademi, Nilufar, Jalali, Soheila, Shokri-Mashhadi, Nafiseh. Risk Factors for the Mortality in Hospitalized Patients with COVID-19: A Brief Report. سامانه مدیریت نشریات علمی, 1400; 46(6): 487-492. doi: 10.30476/ijms.2021.47835

Risk Factors for the Mortality in Hospitalized Patients with COVID-19: A Brief Report

Iranian Journal of Medical Sciences
مقاله 9، دوره 46، شماره 6، بهمن 2021، صفحه 487-492    اصل مقاله (253.63 K)
نوع مقاله: Brief Report(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2021.47835
نویسندگان
Ramin Sami1؛ Mohammad-Reza Hajian1؛ Babak Amra2؛ Forogh Soltaninejad1؛ Marjan Mansourian3؛ Sam Mirfendereski4؛ Raheleh Sadegh5؛ Nilufar Khademi1؛ Soheila Jalali6؛ Nafiseh Shokri-Mashhadi* 7
1Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2Bamdad Respiratory and Sleep Research Center, Department of Internal Medicine, Pulmonary and Sleep Ward, Isfahan University of Medical Sciences, Isfahan, Iran
3Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
4Department of Radiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
5Department of Community and Prevention Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
6Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
7Department of Clinical Nutrition, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
چکیده
The cumulative rate of death of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has necessitated better recognizing the risk factors of the disease and the COVID-19-induced mortality. This cross-sectional study aimed to determine the potential risk factors that predict COVID-19-related mortality concentrating on the initial recorded laboratory tests. We extracted admission’s medical records of a total of 136 deaths related to COVID-19 and 272 discharged adult inpatients (≥18 years old) related to four referral centers from February 24th to April 12th, 2020, in Isfahan, Iran, to figure out the relationship between the laboratory findings and mortality beyond demographic and clinical findings. We applied the independent sample t test and a chichi square test with SPSS software to compare the differences between the survivor and non-survivor patients. A P value of less than 0.05 was considered significant. Our results showed that greater length of hospitalization (P≤0.001), pre-existing chronic obstructive pulmonary disease (P≤0.001), high pulse rate, hypoxia (P≤0.001), and high computed tomography scan score (p <0.001), in addition to high values of some laboratory parameters, increase the risk of mortality. Moreover, high neutrophil/lymphocyte ratio (OR, 1.890; 95% CI, 1.074-3.325, P=0.027), increased creatinine levels (OR, 15.488; 95% CI, 0.801-299.479, P=0.07), and elevated potassium levels (OR, 13.400; 95% CI, 1.084-165.618, P=0.043) independently predicted in-hospital death related to COVID-19 infection. These results emphasized the potential role of impaired laboratory parameters for the prognosis of fatal outcomes in adult inpatients. 
کلیدواژه‌ها
COVID-19؛ Risk factors؛ Mortality؛ Medical laboratory science
سایر فایل های مرتبط با مقاله
مراجع
  1. Organization WH [Internet]. WHO Director-General’s opening remarks at the media briefing on COVID-19. [cited 11 March 2020]. https://www.who.int/dg/speeches/detail/ who-director-general-s-opening-remarks-atthe-media-briefing-on-covid-19—11-march-2020
  2. Organization WH. COVID-19 weekly epidemiological update, 16 March 2021. Geneva, World Health Organization.
  3. Mohammed R. The prevalence study of coronavirus disease (Covid-19) cases in Asia, Europe and Middle East. IJARESM. 2012;9.
  4. Abdollahpour I, Aguilar-Palacio I, Gonzalez-Garcia J, Vaseghi G, Otroj Z, Manteghinejad A, et al. Model Prediction for In-Hospital Mortality in Patients with COVID-19: A Case-Control Study in Isfahan, Iran. Am J Trop Med Hyg. 2021. doi: 10.4269/ajtmh.20-1039. PubMed PMID: 33591938; PubMed Central PMCID: PMCPMC8045635.
  5. Moein S, Nickaeen N, Roointan A, Borhani N, Heidari Z, Javanmard SH, et al. Forecasting Covid-19 epidemic in Isfahan using a dynamic modeling approach. 2020. doi: 10.21203/rs.3.rs-33175/v1.
  6. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430-6. doi: 10.1038/s41586-020-2521-4. PubMed PMID: 32640463; PubMed Central PMCID: PMCPMC7611074.
  7. Janani M, Beheshti-Nia F, Ahmadi H, Khazeni A, Yadegarafar G. Epidemiological features and hotspot of COVID-19 in Isfahan province of Iran: Results of a cohort study. 2020. doi: 10.21203/rs.3.rs-38143/v1.
  8. Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24:179. doi: 10.1186/s13054-020-02902-w. PubMed PMID: 32345311; PubMed Central PMCID: PMCPMC7187660.
  9. Sabri A, Davarpanah AH, Mahdavi A, Abrishami A, Khazaei M, Heydari S, et al. Novel coronavirus disease 2019: predicting prognosis with a computed tomography-based disease severity score and clinical laboratory data. Pol Arch Intern Med. 2020;130:629-34. doi: 10.20452/pamw.15422. PubMed PMID: 32500700.
  10. Sule WF, Oluwayelu DO. Real-time RT-PCR for COVID-19 diagnosis: challenges and prospects. Pan Afr Med J. 2020;35:121. doi: 10.11604/pamj.supp.2020.35.24258. PubMed PMID: 33282076; PubMed Central PMCID: PMCPMC7687508.
  11. Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS One. 2020;15:e0238215. doi: 10.1371/journal.pone.0238215. PubMed PMID: 32845926; PubMed Central PMCID: PMCPMC7449476.
  12. Rabbani G, Shariful Islam SM, Rahman MA, Amin N, Marzan B, Robin RC, et al. Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis. Expert Rev Respir Med. 2021;15:705-16. doi: 10.1080/17476348.2021.1866547. PubMed PMID: 33334189.
  13. Aveyard P, Gao M, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. The lancet Respiratory medicine. 2021. doi: 10.1016/S2213-2600(21)00095-3.
  14. VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E-Value. Ann Intern Med. 2017;167:268-74. doi: 10.7326/M16-2607. PubMed PMID: 28693043.
  15. Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, et al. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020;14:690-700. doi: 10.1007/s12072-020-10072-8. PubMed PMID: 32623632; PubMed Central PMCID: PMCPMC7334898.
  16. Yan X, Li F, Wang X, Yan J, Zhu F, Tang S, et al. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study. J Med Virol. 2020;92:2573-81. doi: 10.1002/jmv.26061. PubMed PMID: 32458459; PubMed Central PMCID: PMCPMC7283791.
  17. Shokri-Mashhadi N, Kazemi M, Saadat S, Moradi S. Effects of select dietary supplements on the prevention and treatment of viral respiratory tract infections: a systematic review of randomized controlled trials. Expert Rev Respir Med. 2021;15:805-21. doi: 10.1080/17476348.2021.1918546. PubMed PMID: 33858268.
  18. Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Baweja M, et al. Acute Kidney Injury in Hospitalized Patients with COVID-19. medRxiv. 2020. doi: 10.1101/2020.05.04.20090944. PubMed PMID: 32511564; PubMed Central PMCID: PMCPMC7274245.
  19. Lee G, Choi S, Kim K, Yun JM, Son JS, Jeong SM, et al. Association of Hemoglobin Concentration and Its Change With Cardiovascular and All-Cause Mortality. J Am Heart Assoc. 2018;7. doi: 10.1161/JAHA.117.007723. PubMed PMID: 29378732; PubMed Central PMCID: PMCPMC5850255.
  20. Leliefeld PH, Wessels CM, Leenen LP, Koenderman L, Pillay J. The role of neutrophils in immune dysfunction during severe inflammation. Crit Care. 2016;20:73. doi: 10.1186/s13054-016-1250-4. PubMed PMID: 27005275; PubMed Central PMCID: PMCPMC4804478.
آمار
تعداد مشاهده مقاله: 3,569
تعداد دریافت فایل اصل مقاله: 2,508


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب